Nov 12, 2025
SGLT2 Inhibitors and Bone Health: What You Need to Know About Fracture Risk
The TRIPS agreement shaped global access to generic medicines by enforcing strict patent rules that delay affordable drugs in poor countries. Despite flexibilities like compulsory licensing, legal and political barriers keep life-saving treatments out of reach for millions.